2022 Presenting Companies
PeLeMed is a biotech company discovering new innovative drugs for incurable diseases. Currently we are focusing on drug resistant Oncology and viral infectious diseases. We have 7 R&D pipelines which are promising and potent, and we acquired 1 IND approval (PLM-401) and 1 non clinical trial (PLM-102) is ongoing.
- The investment stage is Series A bridge funding.- PeLeMed has achieved 11 government funds and programs.